{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:39:53Z","timestamp":1793209193872,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00404-021-06047-1","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T19:02:52Z","timestamp":1617476572000},"page":"1291-1298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The safety and efficacy of a novel method for treatment of HSIL"],"prefix":"10.1007","volume":"304","author":[{"given":"Jian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"issue":"6","key":"6047_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"6047_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.1866","volume":"208","author":"PJ Snijders","year":"2006","unstructured":"Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (2006) HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 208(2):152\u2013164. https:\/\/doi.org\/10.1002\/path.1866","journal-title":"J Pathol"},{"issue":"9590","key":"6047_CR3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/s0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet (London, England) 370(9590):890\u2013907. https:\/\/doi.org\/10.1016\/s0140-6736(07)61416-0","journal-title":"Lancet (London, England)"},{"issue":"10167","key":"6047_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0140-6736(18)32470-x","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet (London, England) 393(10167):169\u2013182. https:\/\/doi.org\/10.1016\/s0140-6736(18)32470-x","journal-title":"Lancet (London, England)"},{"key":"6047_CR5","doi-asserted-by":"publisher","first-page":"i4924","DOI":"10.1136\/bmj.i4924","volume":"355","author":"MG Dijkstra","year":"2016","unstructured":"Dijkstra MG, van Zummeren M, Rozendaal L, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, Meijer CJ, Berkhof J (2016) Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands. BMJ (Clinical research ed) 355:i4924. https:\/\/doi.org\/10.1136\/bmj.i4924","journal-title":"BMJ (Clinical research ed)"},{"issue":"10108","key":"6047_CR6","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/s0140-6736(17)31821-4","volume":"390","author":"WK Huh","year":"2017","unstructured":"Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A (2017) Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: a randomised, double-blind trial. Lancet (London, England) 390(10108):2143\u20132159. https:\/\/doi.org\/10.1016\/s0140-6736(17)31821-4","journal-title":"Lancet (London, England)"},{"key":"6047_CR7","doi-asserted-by":"publisher","first-page":"l1161","DOI":"10.1136\/bmj.l1161","volume":"365","author":"T Palmer","year":"2019","unstructured":"Palmer T, Wallace L, Pollock KG, Cuschieri K, Robertson C, Kavanagh K, Cruickshank M (2019) Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12\u201313 in Scotland: retrospective population study. BMJ (Clinical research ed) 365:l1161. https:\/\/doi.org\/10.1136\/bmj.l1161","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"6047_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00404-018-4881-7","volume":"298","author":"L Jing","year":"2018","unstructured":"Jing L, Dan W, Zhunan L, Ying X, Yi C (2018) Residual lesions in uterine specimens after loop electrosurgical excision procedure in patients with CIN. Arch Gynecol Obstet 298(4):805\u2013812. https:\/\/doi.org\/10.1007\/s00404-018-4881-7","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"6047_CR9","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/(sici)1097-0142(19961101)78:9<1892::aid-cncr8>3.3.co;2-u","volume":"78","author":"T Fujisawa","year":"1996","unstructured":"Fujisawa T, Yamaguchi Y (1996) Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma. Cancer 78(9):1892\u20131898. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19961101)78:9%3c1892::aid-cncr8%3e3.3.co;2-u","journal-title":"Cancer"},{"issue":"1","key":"6047_CR10","first-page":"20","volume":"21","author":"J Zhao","year":"2007","unstructured":"Zhao J, Du HJ, Liao QP (2007) Effect of Nocardia rubra cell wall skeleton on the growth of HeLa cell line infected with HPV. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 21(1):20\u201322","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"issue":"4","key":"6047_CR11","first-page":"340","volume":"21","author":"J Zhao","year":"2007","unstructured":"Zhao J, Zhan SB, Li XQ, Zhou L, Yang YJ, Liao QP (2007) Effect of Nocardia rubra cell wall skeleton (Nr-CWS) on oncogenicity of TC-1 cells and anti-human papillomavirus effect of Nr-CWS in lower genital tract of women. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 21(4):340\u2013342","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"issue":"1","key":"6047_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1365-2303.2002.00397.x","volume":"13","author":"JH Smith","year":"2002","unstructured":"Smith JH (2002) Bethesda 2001. Cytopathol Off J Br Soc Clin Cytol 13(1):4\u201310","journal-title":"Cytopathol Off J Br Soc Clin Cytol"},{"key":"6047_CR13","volume-title":"WHO classification of tumours of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014) WHO classification of tumours of female reproductive organs. International Agency for Research on Cancer (IARC), Lyon"},{"key":"6047_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pdpdt.2015.12.004","volume":"13","author":"Y Fu","year":"2016","unstructured":"Fu Y, Bao Y, Hui Y, Gao X, Yang M, Chang J (2016) Topical photodynamic therapy with 5-aminolevulinic acid for cervical high-risk HPV infection. Photodiagn Photodyn Ther 13:29\u201333. https:\/\/doi.org\/10.1016\/j.pdpdt.2015.12.004","journal-title":"Photodiagn Photodyn Ther"},{"issue":"6","key":"6047_CR15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1097\/01.aog.0000245448.19446.81","volume":"108","author":"AS Case","year":"2006","unstructured":"Case AS, Rocconi RP, Straughn JM, Wang W, Roark K, Waltman EE, Huh WK (2006) Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes. Obstet Gynecol 108(6):1369\u20131374. https:\/\/doi.org\/10.1097\/01.aog.0000245448.19446.81","journal-title":"Obstet Gynecol"},{"issue":"1","key":"6047_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0301-2115(01)00457-2","volume":"100","author":"E Kucera","year":"2001","unstructured":"Kucera E, Sliutz G, Czerwenka K, Breitenecker G, Leodolter S, Reinthaller A (2001) Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 100(1):72\u201376. https:\/\/doi.org\/10.1016\/s0301-2115(01)00457-2","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"6047_CR17","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1043\/1543-2165(2003)127<959:hpdtaa>2.0.co;2","volume":"127","author":"AT L\u00f6rincz","year":"2003","unstructured":"L\u00f6rincz AT, Richart RM (2003) Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 127(8):959\u2013968. https:\/\/doi.org\/10.1043\/1543-2165(2003)127%3c959:hpdtaa%3e2.0.co;2","journal-title":"Arch Pathol Lab Med"},{"key":"6047_CR18","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2147\/cmar.s179724","volume":"10","author":"B Dong","year":"2018","unstructured":"Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, Pan D, Lin F (2018) Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case\u2013control study. Cancer Manag Res 10:4839\u20134851. https:\/\/doi.org\/10.2147\/cmar.s179724","journal-title":"Cancer Manag Res"},{"issue":"2","key":"6047_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","volume":"130","author":"WD Kang","year":"2013","unstructured":"Kang WD, Choi HS, Kim SM (2013) Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 130(2):264\u2013268. https:\/\/doi.org\/10.1016\/j.ygyno.2013.04.050","journal-title":"Gynecol Oncol"},{"issue":"3","key":"6047_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10238-013-0245-6","volume":"14","author":"DY Chang","year":"2014","unstructured":"Chang DY, Song SH, You S, Lee J, Kim J, Racanelli V, Son H, Shin EC (2014) Programmed death-1 (PD-1)-dependent functional impairment of CD4(+) T cells in recurrent genital papilloma. Clin Exp Med 14(3):305\u2013313. https:\/\/doi.org\/10.1007\/s10238-013-0245-6","journal-title":"Clin Exp Med"},{"key":"6047_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ijbiomac.2017.03.060","volume":"101","author":"G Wang","year":"2017","unstructured":"Wang G, Wu J, Miao M, Dou H, Nan N, Shi M, Yu G, Shan F (2017) Nocardia rubra cell-wall skeleton promotes CD4 T cell activation and drives Th1 immune response. Int J Biol Macromol 101:398\u2013407. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.03.060","journal-title":"Int J Biol Macromol"},{"key":"6047_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28182","author":"Y Meng","year":"2019","unstructured":"Meng Y, Sun J, Wang X, Ma Y, Kong C, Zhang G, Dou H, Nan N, Shi M, Yu T, Piao H (2019) The biological macromolecule Nocardia rubra cell-wall skeleton as an avenue for cell-based immunotherapy. J Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.28182","journal-title":"J Cell Physiol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-021-06047-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-021-06047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T03:42:10Z","timestamp":1633405330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-021-06047-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6047"],"URL":"https:\/\/doi.org\/10.1007\/s00404-021-06047-1","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,3]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there is no professional or other personal interest of any nature or kind in any product, service and\/or company that could be construed as influencing the position presented in the manuscript entitled, \u201cThe safety and efficacy of a novel method for treatment of HSIL\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}